|
|
Volumn 23, Issue 11, 2014, Pages 855-857
|
|
Inhibition of STAT3 signalling contributes to the antimelanoma action of atractylenolide II
a
b
a
a
a
a
a
a
a
a
a
c
a
|
|
Author keywords
Atractylenolide II; Melanoma; Src; STAT3
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ATRACTYLENOLIDE II;
PROTEIN BCL XL;
PROTEIN MCL 1;
PROTEIN TYROSINE KINASE;
STAT PROTEIN;
STAT3 PROTEIN;
STAT3C PROTEIN;
UNCLASSIFIED DRUG;
LACTONE;
SESQUITERPENE;
STAT3 PROTEIN, HUMAN;
STAT3 PROTEIN, MOUSE;
A375 CELL LINE;
ANIMAL CELL;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
ANTIPROLIFERATIVE ACTIVITY;
APOPTOSIS;
CELL SURVIVAL;
CONTROLLED STUDY;
ENZYME INHIBITION;
GENE OVEREXPRESSION;
IN VITRO STUDY;
IN VIVO STUDY;
LETTER;
MELANOMA B16;
MELANOMA CELL;
MOUSE;
NONHUMAN;
PROTEIN EXPRESSION;
PROTEIN PHOSPHORYLATION;
SIGNAL TRANSDUCTION;
TUMOR XENOGRAFT;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
C57BL MOUSE;
CHEMISTRY;
DOSE RESPONSE;
DRUG SCREENING;
EXPERIMENTAL MELANOMA;
HUMAN;
MELANOMA;
METABOLISM;
SKIN NEOPLASMS;
TUMOR CELL LINE;
ANIMALS;
ANTICARCINOGENIC AGENTS;
APOPTOSIS;
CELL LINE, TUMOR;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
LACTONES;
MELANOMA;
MELANOMA, EXPERIMENTAL;
MICE;
MICE, INBRED C57BL;
SESQUITERPENES;
SIGNAL TRANSDUCTION;
SKIN NEOPLASMS;
STAT3 TRANSCRIPTION FACTOR;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
|
EID: 84937549341
PISSN: 09066705
EISSN: 16000625
Source Type: Journal
DOI: 10.1111/exd.12527 Document Type: Letter |
|
Times cited : (35)
|
|
References (15)
|
